References
- Donaldson MD, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child 2006;91:513–520.
- Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010;95:1487–1495.
- Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocr Rev 2002;23:120–140.
- Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657–687.
- Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocr Rev 2002;23:120–140.
- Conway GS. The impact and management of Turner’s syndrome in adult life. Best Pract Res Clin Endocrinol Metab 2002;16:243–261.
- Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897–3902.
- Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol 2009;5:569–576.
- Stephure DK; Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90:3360–3366.
- Zeger MP, Shah K, Kowal K, Cutler GB Jr, Kushner H, Ross JL. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Horm Res Paediatr 2011;75:38–46.
- Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol (Oxf) 2009;70:265–273.
- Castelo-Branco C, León M, Durán M, Balasch J. Follicle-stimulating hormone does not directly regulate bone mass in human beings: evidence from nature. Fertil Steril 2008;90:2211–2216.
- Ross J, Roeltgen D, Zinn A. Cognition and the sex chromosomes: studies in Turner syndrome. Horm Res 2006;65:47–56.
- Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod 2005;5:1418–1421
- Foudila T, Söderström-Anttila V, Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod 1999;14:532–535.
- Breuil V, Euller-Ziegler L. Gonadal dysgenesis and bone metabolism. Joint Bone Spine 2001;68:26–33.
- Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord 2008;9:145–151.
- Sass TC, De Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, Van Leeuwen WJ, Van Teunenbroek A, Van Rijn RR, Drop SL. A longitudinal study on bone mineral density until adulthood in girls with Turner’s syndrome participating in a growth hormone injection frequency-response trial. Clin Endocrinol (Oxf) 2000;52:531–536.
- Bondy CA. Heart disease in Turner syndrome. Minerva Endocrinol 2007;32:245–261.
- Thomas J, Yetman AT. Management of cardiovascular disease in Turner syndrome. Expert Rev Cardiovasc Ther 2009;7:1631–1641.
- Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, Platzer M, et al. The DNA sequence of the human X chromosome. Nature 2005;434:325–337.
- Berdahl LD, Wenstrom KD, Hanson JW. Web neck anomaly and its association with congenital heart disease. Am J Med Genet 1995;56:304–307.
- Conway GS, Band M, Doyle J, Davies MC. How do you monitor the patient with Turner’s syndrome in adulthood? Clin Endocrinol (Oxf) 2010;73:696–699.
- Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 2003;290:2127–2128.
- Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH. Increased prevalence of autoimmunity in Turner syndrome–influence of age. Clin Exp Immunol 2009;156:205–210.
- Persani L, Rossetti R, Cacciatore C, Bonomi M. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009;33:35–41.
- Larizza D, Calcaterra V, Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009;33:25–30.
- Su MA, Stenerson M, Liu W, Putnam A, Conte F, Bluestone JA, Anderson MS. The role of X-linked FOXP3 in the autoimmune susceptibility of Turner Syndrome patients. Clin Immunol 2009;131:139–144.
- Hernández-Molina G, Svyryd Y, Sánchez-Guerrero J, Mutchinick OM. The role of the X chromosome in immunity and autoimmunity. Autoimmun Rev 2007;6:218–222.
- Parkin M, Walker P. Hearing loss in Turner syndrome. Int J Pediatr Otorhinolaryngol 2009;73:243–247.
- Kesler SR. Turner syndrome. Child Adolesc Psychiatr Clin N Am 2007;16:709–722.
- Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon JP, Craen M, De Schepper J, et al.; Belgian Study Group of Paediatric Endocrinology. Health and psychosocial status of patients with turner syndrome after transition to adulthood: the Belgian experience. Horm Res 2004;62:161–167.
- Bondy C, Bakalov VK, Lange ED, Ceniceros I. Deficient medical care for adults with the Turner syndrome. Ann Intern Med 2006;145: 866–867.